Myotoxicity [myotoxicita]

topical
1
Terms

léková myopatie
lékové myopatie
myopatie indukovaná léky
myopatie indukované léky
myopatie vyvolaná léky
myopatie vyvolané léky
syndrom myalgie-artralgie
toxická myopatie
toxické myopatie

 

Drug Associated Myopathies
Drug Induced Myopathies
Drug Related Myopathies
Myalgia-Arthralgia Syndrome
Toxic Myopathies

Persistent link   https://www.medvik.cz/link/D000081030
Definition

Damage to the muscle or its function secondary to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

DUI
D000081030 MeSH Browser
CUI
M000649545
History note
2020
Public note
2020

Allowable subheadings

BL
blood
CF
cerebrospinal fluid
CL
classification
CO
complications
DI
diagnosis
DG
diagnostic imaging
DH
diet therapy
DT
drug therapy
EC
economics
EN
enzymology
EP
epidemiology
EH
ethnology
ET
etiology 1
GE
genetics
HI
history
IM
immunology
ME
metabolism
MI
microbiology
MO
mortality
NU
nursing
PS
parasitology
PA
pathology
PP
physiopathology
PC
prevention & control
PX
psychology
RT
radiotherapy
RH
rehabilitation
SU
surgery
TH
therapy
UR
urine
VE
veterinary
VI
virology

C Diseases
C05 Musculoskeletal Diseases 1 140
C05.651 Muscular Diseases 557
C05.651.102 Arthrogryposis 31
C05.651.180 Compartment Syndromes 115
C05.651.197 Contracture 154
C05.651.243 Craniomandibular Disorders 9
C05.651.290 Eosinophilia-Myalgia Syndrome 3
C05.651.310 Fatigue Syndrome, Chronic 276
C05.651.324 Fibromyalgia 134
C05.651.392 Isaacs Syndrome 7
C05.651.426 Medial Tibial Stress Syndrome 2
C05.651.460 Mitochondrial Myopathies 40
C05.651.475 Muscle Cramp 176
C05.651.494 Muscle Neoplasms 17
C05.651.504 Muscle Rigidity 47
C05.651.512 Muscle Spasticity 468
C05.651.515 Muscle Weakness 226
C05.651.534 Muscular Disorders, Atrophic 45
C05.651.538 Musculoskeletal Pain 153
C05.651.542 Myalgia 55
C05.651.550 Myofascial Pain Syndromes 92
C05.651.575 Myopathies, Structural, Congenital 15
C05.651.594 Myositis 256
C05.651.662 Myotonic Disorders 23
C05.651.682 Myotoxicity 1
C05.651.701 Paralyses, Familial Periodic 7
C05.651.742 Polymyalgia Rheumatica 113
C05.651.807 Rhabdomyolysis 130
C05.651.869 Tendinopathy 92
C10 Nervous System Diseases 1 904
C10.668 Neuromuscular Diseases 338
C10.668.491 Muscular Diseases 557
C10.668.491.050 Eosinophilia-Myalgia Syndrome 3
C10.668.491.087 Medial Tibial Stress Syndrome 2
C10.668.491.175 Muscular Disorders, Atrophic 45
C10.668.491.425 Fibromyalgia 134
C10.668.491.500 Mitochondrial Myopathies 40
C10.668.491.525 Myalgia 55
C10.668.491.550 Myopathies, Structural, Congenital 15
C10.668.491.562 Myositis 256
C10.668.491.606 Myotonic Disorders 23
C10.668.491.628 Myotoxicity 1
C10.668.491.650 Paralyses, Familial Periodic 7
C23 Pathological Conditions, Signs and Symptoms 451
C23.550 Pathologic Processes 195
C23.550.035 Acantholysis 10
C23.550.073 Arrhythmias, Cardiac 2 819
C23.550.081 Ascites 336
C23.550.113 Atrial Remodeling 14
C23.550.145 Azotemia 5
C23.550.161 Cardiotoxicity 145
C23.550.177 Channelopathies 14
C23.550.210 Chromosome Aberrations 1 580
C23.550.260 Death 1 417
C23.550.274 Dehydration 403
C23.550.277 Delayed Graft Function 25
C23.550.288 Disease 1 716
C23.550.291 Disease Attributes 1 208
C23.550.308 Dysbiosis 111
C23.550.325 Emphysema 89
C23.550.340 Extravasation of Diagnostic and Therapeutic Materials 37
C23.550.347 Femoracetabular Impingement 27
C23.550.355 Fibrosis 369
C23.550.359 Frailty 125
C23.550.362 Genomic Instability 92
C23.550.369 Gliosis 39
C23.550.382 Granuloma 236
C23.550.384 Granulomatosis, Orofacial 6
C23.550.393 Growth Disorders 642
C23.550.403 Hemolysis 387
C23.550.414 Hemorrhage 2 308
C23.550.421 Hyperammonemia 31
C23.550.425 Hyperamylasemia 5
C23.550.429 Hyperbilirubinemia 185
C23.550.444 Hyperplasia 341
C23.550.449 Hyperuricemia 231
C23.550.455 Hypovolemia 88
C23.550.470 Inflammation 3 511
C23.550.505 Intraoperative Complications 719
C23.550.513 Ischemia 1 742
C23.550.522 Leukoaraiosis 4
C23.550.526 Leukocytosis 100
C23.550.537 Lithiasis 87
C23.550.543 Long Term Adverse Effects 7
C23.550.548 Malacoplakia 4
C23.550.568 Menstruation Disturbances 353
C23.550.589 Metaplasia 98
C23.550.695 Muscle Weakness 226
C23.550.706 Myotoxicity 1
C23.550.717 Necrosis 842
C23.550.722 Neointima 8
C23.550.727 Neoplastic Processes 131
C23.550.737 Nerve Degeneration 167
C23.550.744 Ochronosis 42
C23.550.751 Ossification, Heterotopic 141
C23.550.753 Ototoxicity 11
C23.550.755 Pigmentation Disorders 133
C23.550.759 Polydipsia 18
C23.550.767 Postoperative Complications 7 135
C23.550.770 Protein Aggregation, Pathological 17
C23.550.773 Respiratory Aspiration 80
C23.550.794 Retropneumoperitoneum 14
C23.550.823 Sclerosis 85
C23.550.835 Shock 411
C23.550.863 Teratogenesis 28
C23.550.877 Toxic Optic Neuropathy 1
C23.550.891 Ulcer 201
C23.550.918 Vascular Remodeling 30
C23.550.945 Yang Deficiency 9
C23.550.972 Yin Deficiency 9
C25 Chemically-Induced Disorders 30
C25.100 Drug-Related Side Effects and Adverse Reactions 5 114
C25.100.249 Akathisia, Drug-Induced 29
C25.100.311 Anticholinergic Syndrome 10
C25.100.389 Cardiotoxicity 145
C25.100.429 Chemotherapy-Related Cognitive Impairment 5
C25.100.468 Drug Hypersensitivity 546
C25.100.562 Chemical and Drug Induced Liver Injury 273
C25.100.656 Ototoxicity 11
C25.100.750 Dyskinesia, Drug-Induced 59
C25.100.781 Injection Site Reaction 12
C25.100.812 Metabolic Side Effects of Drugs and Substances 50
C25.100.828 Myotoxicity 1
C25.100.844 Propofol Infusion Syndrome 3
C25.100.875 Serotonin Syndrome 58
C25.100.937 Toxic Optic Neuropathy 1
C26 Wounds and Injuries 1 962
C26.733 Radiation Injuries 688
C26.733.031 Abnormalities, Radiation-Induced 8
C26.733.188 Acute Radiation Syndrome 14
C26.733.266 Cardiotoxicity 145
C26.733.345 Leukemia, Radiation-Induced 23
C26.733.411 Myotoxicity 1
C26.733.476 Neoplasms, Radiation-Induced 126
C26.733.579 Osteoradionecrosis 21
C26.733.650 Ototoxicity 11
C26.733.685 Radiation Fibrosis Syndrome 1
C26.733.720 Radiation Injuries, Experimental 467
C26.733.762 Radiation Pneumonitis 29
C26.733.804 Radiodermatitis 76
C26.733.853 Foveomacular Retinitis
C26.733.902 Toxic Optic Neuropathy 1

G Phenomena and Processes
G01 Physical Phenomena 81
G01.750 Radiation 226
G01.750.748 Radiation Exposure 108
G01.750.748.500 Radiation Injuries 688
G01.750.748.500.031 Abnormalities, Radiation-Induced 8
G01.750.748.500.188 Acute Radiation Syndrome 14
G01.750.748.500.266 Cardiotoxicity 145
G01.750.748.500.345 Leukemia, Radiation-Induced 23
G01.750.748.500.411 Myotoxicity 1
G01.750.748.500.476 Neoplasms, Radiation-Induced 126
G01.750.748.500.579 Osteoradionecrosis 21
G01.750.748.500.650 Ototoxicity 11
G01.750.748.500.685 Radiation Fibrosis Syndrome 1
G01.750.748.500.720 Radiation Injuries, Experimental 467
G01.750.748.500.762 Radiation Pneumonitis 29
G01.750.748.500.804 Radiodermatitis 76
G01.750.748.500.853 Foveomacular Retinitis
G01.750.748.500.902 Toxic Optic Neuropathy 1

Back Add